Oscar Health (NYSE:OSCR - Get Free Report) was downgraded by analysts at Wall Street Zen from a "hold" rating to a "sell" rating in a research report issued to clients and investors on Saturday.
Several other research firms also recently commented on OSCR. Baird R W downgraded Oscar Health from a "strong-buy" rating to a "hold" rating in a report on Friday, July 25th. Robert W. Baird reaffirmed a "neutral" rating and set a $14.00 target price (down previously from $28.00) on shares of Oscar Health in a research report on Friday, July 25th. Raymond James Financial cut Oscar Health from an "outperform" rating to a "market perform" rating in a research report on Tuesday, June 24th. Barclays lowered their price objective on Oscar Health from $17.00 to $11.00 and set an "underweight" rating for the company in a research report on Wednesday, July 23rd. Finally, Piper Sandler cut Oscar Health from an "overweight" rating to a "neutral" rating and set a $14.00 price objective for the company. in a research report on Monday, July 14th. Six investment analysts have rated the stock with a sell rating and four have given a hold rating to the company's stock. Based on data from MarketBeat.com, Oscar Health currently has an average rating of "Reduce" and a consensus price target of $12.21.
Read Our Latest Stock Analysis on OSCR
Oscar Health Trading Up 1.2%
Shares of NYSE:OSCR traded up $0.18 during trading on Friday, hitting $15.16. The company had a trading volume of 6,048,429 shares, compared to its average volume of 13,225,139. The stock has a market cap of $3.86 billion, a price-to-earnings ratio of -18.72 and a beta of 1.86. Oscar Health has a one year low of $11.20 and a one year high of $23.79. The company has a fifty day simple moving average of $15.94 and a two-hundred day simple moving average of $14.83. The company has a debt-to-equity ratio of 0.26, a current ratio of 0.86 and a quick ratio of 0.86.
Oscar Health (NYSE:OSCR - Get Free Report) last issued its quarterly earnings results on Wednesday, August 6th. The company reported ($0.89) earnings per share for the quarter, topping the consensus estimate of ($0.90) by $0.01. Oscar Health had a negative return on equity of 13.78% and a negative net margin of 1.50%. The firm had revenue of $2.86 billion for the quarter, compared to the consensus estimate of $2.88 billion. During the same period in the prior year, the business posted $0.20 earnings per share. The company's revenue for the quarter was up 29.0% on a year-over-year basis. As a group, equities analysts forecast that Oscar Health will post 0.69 earnings per share for the current year.
Institutional Trading of Oscar Health
Several hedge funds have recently modified their holdings of the stock. LRI Investments LLC increased its holdings in Oscar Health by 377.9% in the second quarter. LRI Investments LLC now owns 1,233 shares of the company's stock valued at $26,000 after buying an additional 975 shares during the last quarter. Atlantic Union Bankshares Corp purchased a new position in Oscar Health in the second quarter valued at $33,000. Jones Financial Companies Lllp grew its holdings in shares of Oscar Health by 7,473.3% during the first quarter. Jones Financial Companies Lllp now owns 2,272 shares of the company's stock worth $30,000 after purchasing an additional 2,242 shares during the last quarter. Strs Ohio purchased a new position in shares of Oscar Health during the first quarter worth about $30,000. Finally, Larson Financial Group LLC grew its holdings in shares of Oscar Health by 83,733.3% during the first quarter. Larson Financial Group LLC now owns 2,515 shares of the company's stock worth $33,000 after purchasing an additional 2,512 shares during the last quarter. 75.70% of the stock is currently owned by institutional investors and hedge funds.
Oscar Health Company Profile
(
Get Free Report)
Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.
Featured Stories

Before you consider Oscar Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oscar Health wasn't on the list.
While Oscar Health currently has a Strong Sell rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.